A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters
Open Access
- 1 July 2005
- journal article
- clinical trial
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 289 (1) , E75-E81
- https://doi.org/10.1152/ajpendo.00571.2004
Abstract
Type II deiodinase (D2) is important in the regulation of local thyroid hormone bioactivity in certain tissues. D2 in skeletal muscle may also play a role in serum triiodothyronine (T3) production. In this study, we identified a polymorphism in the 5′-UTR of the D2 gene (D2-ORFa-Gly3Asp). We investigated the association of D2-ORFa-Gly3Asp, and of the previously identified D2-Thr92Ala polymorphism, with serum iodothyronine levels. D2-ORFa-Gly3Asp was identified by sequencing the 5′-UTR of 15 randomly selected individuals. Genotypes for D2-ORFa-Gly3Asp were determined in 156 healthy blood donors (age 46.3 ± 12.2 yr) and 349 ambulant elderly men (age 77.7 ± 3.5 yr) and related to serum iodothyronine and TSH levels. D2-ORFa-Asp3 had an allele frequency of 33.9% in blood bank donors and was associated with serum thyroxine (T4; Gly/Gly vs. Gly/Asp vs. Asp/Asp = 7.06 ± 0.14 vs. 6.74 ± 0.15 vs. 6.29 ± 0.27 μg/dl, P = 0.01), free T4 (1.22 ± 0.02 vs. 1.16 ± 0.02 vs. 1.06 ± 0.04 ng/dl, P = 0.001), reverse T3 ( P = 0.01), and T3/T4 ratio ( P = 0.002) in a dose-dependent manner, but not with serum T3 ( P = 0.59). In elderly men, D2-ORFa-Asp3 had a similar frequency but was not associated with serum iodothyronine levels. This new polymorphism in the 5′-UTR of D2 is associated with iodothyronine levels in blood donors but not in elderly men. We hypothesize that this might be explained by the decline in skeletal muscle size during aging, resulting in a relative decrease in the contribution of D2 to serum T3 production.Keywords
This publication has 45 references indexed in Scilit:
- Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine SelenodeiodinasesEndocrine Reviews, 2002
- A New Statistical Method for Haplotype Reconstruction from Population DataAmerican Journal of Human Genetics, 2001
- Isolation of Human Type 2 Deiodinase Gene Promoter and Characterization of a Functional Cyclic Adenosine Monophosphate Response ElementEndocrinology, 2000
- Characterization of the 5'-Flanking and 5'-Untranslated Regions of the Cyclic Adenosine 3',5'-Monophosphate-Responsive Human Type 2 Iodothyronine Deiodinase GeneEndocrinology, 2000
- Thyroid hormone and other regulators of uncoupling proteinsInternational Journal of Obesity, 1999
- Luteinizing Hormone and Different Genetic Variants, as Indicators of Frailty in Healthy Elderly MenJournal of Clinical Endocrinology & Metabolism, 1999
- Thyroid Hormone Control of Thermogenesis and Energy BalanceThyroid®, 1995
- Alterations in 3,3'5'-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man.Journal of Clinical Investigation, 1989
- Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man.Journal of Clinical Investigation, 1975
- Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man.Journal of Clinical Investigation, 1975